Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris

C. auris is an emerging human fungal pathogen that has been recently implicated in several nosocomial outbreaks worldwide [1, 2]. Although outbreaks have been reported in many countries, the true prevalence of C. auris infections is likely to be underestimated. This is mainly because identification of C. auris requires special diagnostic tools such as MALDI-TOF mass spectrometry or more complicated molecular techniques such as multilocus sequence typing, which are not readily available in many countries [3-7].
Source: International Journal of Antimicrobial Agents - Category: Drugs & Pharmacology Authors: Source Type: research